FEVER IN THE COMPROMISED HOST
- 1 March 1996
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 10 (1) , 129-148
- https://doi.org/10.1016/s0891-5520(05)70291-9
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerAntimicrobial Agents and Chemotherapy, 1995
- Bacteremia due to viridans streptococci in neutropenic patients: A reviewThe American Journal of Medicine, 1994
- Primary Cutaneous Fungal Infection after Solid-Organ Transplantation: Report of Five Cases and ReviewClinical Infectious Diseases, 1992
- Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and ReviewClinical Infectious Diseases, 1992
- High-Resolution Ultrafast Chest CT in the Clinical Management of Febrile Bone Marrow Transplant Patients with Normal or Nonspecific Chest RoentgenogramsChest, 1991
- Naproxen test Usefulness in differential diagnosis between infectious and neoplastic fever in cancer patientsInfectious Diseases Newsletter, 1989
- Rapid Detection of Cytomegalovirus Pulmonary Infection by Bronchoalveolar Lavage and Centrifugation CultureAnnals of Internal Medicine, 1988
- Drug-induced pulmonary diseaseDisease-a-Month, 1987
- Infection in cancer patients: A continuing associationThe American Journal of Medicine, 1986
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966